BlackRock »

Ovid Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.1M 4.3M 1.18

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Ovid Therapeutics

Rubric Capital Management
BlackRock
BlackRock
BVF
Vanguard Group
Siren
Acadian Asset Management
Kennedy Capital Management
Jpmorgan Chase & Co
Driehaus Capital Management
State Street Corporation
Geode Capital Management
TLS Advisors
Wells Fargo & Company
Northern Trust

View all funds holding Ovid Therapeutics